Influx Healthtech IPO is a bookbuilding of ₹55.63 crores. The issue is a combination of fresh issue of 46.94 lakh shares aggregating to ₹45.07 crores and offer for sale of 11.00 lakh shares aggregating to ₹10.56 crores.
Influx Healthtech IPO bidding opened for subscription on June 18, 2025 and will close on June 20, 2025. The allotment for the Influx Healthtech IPO is expected to be finalized on Monday, June 23, 2025. Influx Healthtech IPO will be list on NSE SME with a tentative listing date fixed as Wednesday, June 25, 2025.
Influx Healthtech IPO price band is set at ₹91 to ₹96 per share. The minimum lot size for an application is 1200. The minimum amount of investment required by retail investors is ₹1,09,200. But it is suggested to the investor to bid at the cutoff price to avoid the oversubscription senerio, which is about to ₹1,15,200. The minimum lot size investment for HNI is 2 lots (2,400 shares) amounting to ₹2,30,400.
Incorporated in September 2020, Influx Healthtech Limited is a healthcare-focused company specializing in contract manufacturing. As a trusted Contract Development and Manufacturing Organization (CDMO), it offers a wide range of specialized services to clients across various industries. The company operates three manufacturing facilities in Thane, Maharashtra, spread across areas of 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft., respectively.
Influx Healthtech’s diverse product portfolio includes tablets, capsules, powders, liquid orals, softgels, lozenges, jellies, gummies, oral dispersible films (ODFs), effervescent tablets, and liquid-fill capsules. It also manufactures candies, gym and sports supplements, skincare and body care products, hair and beard care solutions, face masks, soaps, ayurvedic and herbal formulations, veterinary feed supplements, and homecare solutions.
The company supports nutraceutical and cosmetic firms by providing end-to-end solutions that cover product development, manufacturing, and regulatory support, allowing its clients to focus on formulation and market expansion.
IPO stands for "Initial Public Offering." It's the process through which a privately-held company becomes publicly traded by offering its shares to the general public and listing them on a stock exchange for trading. This allows the company to raise capital from investors and grants individuals and institutions the opportunity to invest in and own a portion of the company.
The life cycle of an IPO, or Initial Public Offering, begins with a company's decision to go public. It involves hiring underwriters, registering with regulatory authorities, determining the IPO price, marketing to investors, and the subscription period where investors place orders for shares. After allocation and listing, shares become publicly tradable, and the company enters the secondary market. Ongoing reporting and corporate governance are crucial as the company continues to operate as a publicly-traded entity. The IPO aims to raise capital for growth and provides investors with opportunities to trade shares in the company.
An IPO (Initial Public Offering) is when a private company goes public by selling shares to the public. Investors buy these shares, giving them ownership in the company. It's a way for companies to raise capital and expand. The process involves underwriters, regulatory filings, setting the IPO price, and marketing to investors. After the IPO, shares can be traded on a stock exchange. IPOs offer opportunities and risks, so investors should research and consider carefully.
"Upcoming IPOs" refers to initial public offerings that have been announced by private companies but have not yet occurred. These are companies that plan to go public in the near future by issuing shares to the public and listing them on a stock exchange. Investors often keep an eye on upcoming IPOs as they represent opportunities to invest in companies at their early stages of public trading, potentially capturing growth potential. These offerings are typically accompanied by significant media and investor attention as they approach their launch dates.